Librede Inc. Awarded Highly Competitive Phase II SBIR Grant From NIH

Librede Cannabinoid Map

CALIFORNIA: Librede, an early stage biotechnology company, has been awarded a $1,490,000 Phase II Small Business Innovative Research Grant (SBIR) from the National Center for Complementary and Integrative Health (NCCIH), part of the National Institutes of Health (NIH), to further develop and scale their proprietary yeast-based cannabinoid production platform. The NIH SBIR program is a highly Read the full article…